BMRN PEER ANALYSIS

Biomarin Pharmaceutical Inc — metric-by-metric comparison with peers and the industry median

BMRNBiomarin Pharmaceutical Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

BMRNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BMRN	CSL	TLX	MSB	Ind. Median
P/E	44.39	29.96●	—	—	18.06
P/B	1.92●	2.24	6.38	—	3.62
EV/EBITDA	23.10	10.35●	120.20	—	15.13
P/S	3.68	2.66●	3.24	31.30	10.65

Financial Health
Metric	BMRN	CSL	TLX	MSB	Ind. Median
Current Ratio	5.81●	2.57	1.43	—	5.90
Debt/Equity	23.2%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-1.62●	2.22	13.13	—	1.15

Profitability
Metric	BMRN	CSL	TLX	MSB	Ind. Median
Net Margin	8.3%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	4.5%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	3.4%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	14.9%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	BMRN	CSL	TLX	MSB	Ind. Median
Rev. Growth	9.9%	4.8%	56.3%	410.4%●	5.1%
NI Growth	-48.7%	-39.4%●	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	BMRN	KRYS	ARWR	TECH	KYMR	AXSM	Ind. Median
P/E	44.39●	49.97	—	101.14	—	—	18.06
P/B	1.92●	8.81	20.17	5.31	7.55	234.26	3.62
EV/EBITDA	23.10●	51.98	—	43.27	—	—	15.13
P/S	3.68●	26.95	19.91	9.15	225.98	18.06	10.65

Financial Health
Metric	BMRN	KRYS	ARWR	TECH	KYMR	AXSM	Ind. Median
Current Ratio	5.81	9.46	6.23	4.49	10.81●	1.39	5.90
Debt/Equity	23.2%	0.7%●	223.7%	13.9%	5.2%	402.8%	10.9%
NetDebt/EBITDA	-1.62	-4.06●	3.06	0.31	1.86	0.49	1.15

Profitability
Metric	BMRN	KRYS	ARWR	TECH	KYMR	AXSM	Ind. Median
Net Margin	8.3%	53.9%●	-48.4%	9.0%	-612.2%	-26.6%	-125.7%
ROE	4.5%	19.9%●	-46.4%	5.3%	-27.1%	-349.4%	-47.5%
ROA	3.4%	18.2%●	-15.7%	4.2%	-24.4%	-28.7%	-35.8%
EBITDA Margin	14.9%	48.1%●	-21.6%	21.3%	-594.7%	-24.4%	-105.8%

Growth + Dividend
Metric	BMRN	KRYS	ARWR	TECH	KYMR	AXSM	Ind. Median
Rev. Growth	9.9%	25.1%	9.4%	0.2%	-12.6%	63.9%●	5.1%
NI Growth	-48.7%	81.5%●	—	-16.8%	—	—	12.1%
Div. Yield	—	—	0.3%	0.5%●	—	—	0.2%
Payout	—	—	-13.8%	45.5%	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BMRN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.